
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Chromium picolinate is a highly bioavailable form of chromium bound to picolinic acid that enhances insulin sensitivity and glucose metabolism. The picolinic acid chelation increases chromium absorption by up to 20-fold compared to inorganic chromium forms.

Reported Benefits (Provisional)
Origin & History

Chromium picolinate is a chemical compound that combines chromium with picolinic acid. It is produced by binding chromium to picolinic acid to enhance its absorption and bioavailability. This form is commonly used in supplements aimed at supporting metabolic health.
Research Narrative (Provisional)
Several randomized controlled trials have demonstrated chromium picolinate's role in improving insulin sensitivity and supporting weight management. Meta-analyses suggest potential benefits for blood sugar control.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Provides chromium, an essential trace mineral for glucose metabolism. - Picolinic acid enhances chromium absorption. - Supports carbohydrate, fat, and protein metabolism.
Reported Mechanism (Provisional)
Chromium picolinate activates insulin receptor kinase and enhances glucose transporter-4 (GLUT-4) translocation to cell membranes, improving glucose uptake. The chromium ion potentiates insulin signaling by activating protein kinase B (AKT) and enhancing the insulin receptor substrate-1 (IRS-1) phosphorylation cascade. Picolinic acid facilitates chromium transport across intestinal membranes via amino acid transporters.
Clinical Narrative (Provisional)
Multiple randomized controlled trials involving 1,690 participants show chromium picolinate supplementation (200-400 mcg daily) reduces HbA1c by 0.5-0.8% and fasting glucose by 15-25 mg/dL in type 2 diabetics. Weight loss studies demonstrate modest reductions of 1.1-2.4 kg over 12-24 weeks, primarily through reduced carbohydrate cravings. Meta-analyses indicate stronger effects in individuals with insulin resistance or diabetes compared to healthy populations. Evidence quality is moderate with some studies showing publication bias.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







